The development and implementation of test systems in pharmacy practice could be one of the ways of optimization of the quality control of compounded preparations. Test kits, which have been manufactured in a pharmacy, are simple, cheap and effective for the quality control of a wide range of pharmaceutical preparations. Guidelines for quality must be taken into account during the production of such test kits to enable a pharmacist-analyst to fully perform his tasks using these analytical tools.
INTRODUCTION
Quality control of the compounded preparations is not the only uncontested mechanism of ensuring the quality of medicines. Methods of risk analysis and management in the pharmaceutical industry are implemented in many countries (1, 2) , including Ukraine, in accordance with the guideline ICH-Q9 «Quality Risk Management". The recom-storming", the main stages of the life cycle of test systems have been allocated with further distribution of these risks. The Ishikawa`s diagrams were constructed with attraction of specialists who participated in the designing, manufacturing and use of these analytical tools.
Failure Mode, Effects and Criticality Analysis (FMECA) has found application in pharmacies in Europe (9) . This method of analysis was important for us because of the possibility of digital expression of risks -determining Risk Priority Number -(RPN). RPN is the product probability of occurrence of risk (O), severity of risk (S) and probability of detection of risk (D), calculated for each individual risk. To assess each factor a 10-point scale provided in (8) has been used. The priority number of risk was calculated using the following formula based on the data (7, 10) :
The data were obtained by questioning respondents -pharmacists and laboratory technician assistants who participated in the development, manufacturing, quality control and use of test-systems described in (4) (5) (6) . 30 specialists were interviewed.
RESULTS AND DISCUSSION

Ishikawa`s diagrams or Fishbone diagrams
The factors that have a negative impact on the quality control of compounded preparations by using the test kits reflect in the Ishikawa diagram on Figure 1 . The risks are distributed in 4 stages: the risks of manufacturing, quality control, use and storage of the test kits; the impact of personnel training is presented separately, as it has influence on all stages of the lifecycle of test kits.
The largest group of risks is the risks that impact the process of manufacturing of the test kits. We have represented it separately in the Figure 2 . Figure 1 and Figure 2 show the stage of the manufacturing of test systems has the largest number of risks of the first and second order. This situation is associated with a large number of operations at this stage (Table 1) . mendations of this guideline can be applied not only to the pharmaceutical companies, but also in the pharmacies, which are engaged in compounding and dispensing preparations (3) .
With the purpose of express analysis of compounded preparations test systems containing heavy metals were developed. In previous publications the use of test kits based on filter paper and modified with reagents has been discussed (4) (5) (6) . Using such test systems and physical immobilization of reagents makes the preparation of test kits easily available in pharmacies. Creation of simple, cheap and standardized test systems, with reagents that worked well during the macroanalysis is important and can greatly simplify the process of in-pharmacy quality control. Implementation of new processes -preparation of test systems in compounding pharmacies, making mistakes can lead to the incorrect evaluation of the quality of compounded preparations. Test systems are the tools used for quality control of medicines so the requirements for analysis and risk management can be extended to all stages of the lifecycle of these analytical tools.
The aim of the work is to analyze the risks that may occur during the lifecycle of test systems; to establish the risks that have the biggest impact on quality control of compounded preparations with these analytical tools and to determine the major ways to minimize the impact of risks at all stages of working with test systems.
MATERIALS AND METHODS
Potential risks and ways to avoid them during the lifecycle of test system based on filter paper impregnated with the salts of heavy metals FeCl 3 , CuSO 4 , CoCl 2 are discussed in the article. Methods concerning manufacturing, storage and using these test systems were described in previous publications (4-6).
The following tools were used to analyze the risks during the lifecycle of test systems: Ishikawa diagrams or Fishbone diagrams and Failure Mode, Effects and Criticality Analysis (FMECA).
Ishikawa`s diagrams have wide application in various fields of human activity; they can also be effectively used in pharmacy, including in the work of a pharmacy shop (7, 8) . The analysis of potential risks was conducted using the method of "brain-
Failure Mode, Effects and Criticality Analysis
The risks and their possible effects were analyzed in more details by questioning the specialists, followed by the processing of data using FME-CA. The results of the questioning about the risks and their consequences that may occur at each phase of all 4 stages of the lifecycle of test systems are presented in Table. 1. The 35 risks were selected, some of which are repeated, as they are typical for different phases and have different effects on each of them. In particular, this applies to training of the personnel that, unlike Ishikawa diagrams, is not submitted in a separate group. The absolute and relative values of RPN for each risk at all stages of the lifecycle of the test system are presented in Table 1 .
The percentage of impact of each stage and phase on the overall value of RPN was calculated after statistical processing of the questionnaires. The results are presented in Table 2 . Table 1 shows: the manufacturing of the test systems has the highest rate of RPN -54.95%, due to the large number of phases and the risks at each phase; the quality control and the use of the test systems also make a significant contribution in the overall value of RPN: RPN (Quality control) -21.93%, RPN (Using) -18.66%. Selected stages contain different number of phases, and as result, different number of risks, and so more detailed look should be taken at the risks that may occur at each phase of the lifecycle of the test systems:
preparation of the reagent solution -20.24%; this high index is caused by a large number of operations, errors of which have a high threat to receive a defective test system; chemical analysis -17.93%; the risks that occur at this phase include the use of invalidated analysis methods and reagents that do not comply with the requirements of pharmacopoeias, incorrect concentration of the reagent on the surface of the test system, which can cause narrowing of the range of application of a test system; visual fixation of results has RPN of 9.21%. Failure to comply with the time period of observation, the absence of blank experiment and the problems with fixing results (presence of impurities, which can be able to disguise the analytical effect of the studied component) are the main risks at the this phase; training of the personnel, this factor has a low value of RPN at each of the stages, but the total value of "human factors" is 8.89 %, which indicates the inadmissibility of ignoring the increase of the quality of the personnel training; the physical immobilization is an important phase (8.54%) -errors, which take place at this phase can influence the concentration of reagents at the surface of test-system and expiration date; the phases of preparation of filter paper (7.94%) and analysis (4.73%) have high index of RPN, because of the defects of filter papers and the realization of experiments without blank experiment, respectively; packaging and labeling of the test systems (5.79%) and control of the storage conditions (3.18%) also require increased attention, risks at these phas- 
CONCLUSIONS
Manufacturing, quality control, storage and use of test system based on filter paper impregnated with the salts of heavy metals are characterized by a large number of different risks that are able to have a negative impact on the results of chemical analysis of the compound preparations using test-systems. The data presented in the article allow systematizing and ap- portioning risks and their consequences of the priority and developing recommendations to minimize the negative effects of these threats.
The quality control of the compounded preparations using test systems can significantly increase the following of the recommendations which are given in the article.
The list of recommendations is not final; the work on improving existing and developing new test systems is continued.
Improvement of the quality of these test kits allows incorporating these analytical tools into the list of the reagents (National part) that are recommended by the State Pharmacopoeia of Ukraine.
